This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.

Clinigen-Logo.png
  • Mission
  • How we can help
    Pharmaceutical & Biotech Companies
    Healthcare Professionals
    Patient Groups
    Patients
  • Medicines & Services
    Commercial Medicines >
    • CARDIOXANE®
    • ETHYOL®
    • FOSCAVIR®
    • SAVENE® (Non US)
    • TOTECT® (US only)
    • Partnering with Clinigen
    Unlicensed Medicines >
    • Policy Development
    • Asset Strategy
    • Early Access
    • Real World Evidence
    • Post-Trial Access
    • Phased Launch and Non-Launch Markets
    • Medicine Shortages
    • Market Withdrawal/ Discontinuations
    • Consulting Services
    Clinical Trial Services >
    • Comparator Sourcing and Ancillary Supply
    • Direct-to-site
    • Demand Driven Labelling & Distribution
    • Investigator Initiated Trials
    • Technical Consultancy

    Cliniport Medicine Finder

    Cliniport medicine finder provides access to 10,000 licensed and unlicensed products.

    About Cliniport
  • Global offices
    Australia & New Zealand
    Japan
    Singapore
    South Africa
    United Kingdom
    United States
  • Investors
    At a Glance
    Financial Highlights
    Investment Case
    • Business Model
    • Our Track Record
    • Market Overview
    • Strategy
    • Our Businesses
    Share Tools
    Results, Reports and Presentations
    Quantum Archive
    Financial Calendar
    Press Releases
    • Press Releases
    • Regulatory News
    • Email Alerts
    Shareholder Services
    • AGM
    • Registrar Services
    • Major Shareholders
    • Advisor Contacts
    • Analyst Coverage
    AIM Rule 26
    Corporate Governance
    • Corporate Governance Statement
    • Board of Directors
    • Tax Strategy
  • Company
    About Clinigen >
    • History
    • Responsible business
    • Operational excellence
    • Our brands
    Careers
    • Frequently Asked Questions
    • Apply Online
    • Privacy Notice - Applicants
    Newsroom
    • Video Library
    • Press Releases
Cliniport medicine finder
About Cliniport
Login
Clinigen France
Clinigen Germany
Get in touch
Get in touch
  • Mission
  • How we can help
    How we can help
    • Pharmaceutical & Biotech Companies
    • Healthcare Professionals
    • Patient Groups
    • Patients
  • Medicines & Services
    Medicines & Services
    • Commercial Medicines >
      Commercial Medicines >

      Commercial Medicines >

      • CARDIOXANE®
      • ETHYOL®
      • FOSCAVIR®
      • SAVENE® (Non US)
      • TOTECT® (US only)
      • Partnering with Clinigen
    • Unlicensed Medicines >
      Unlicensed Medicines >

      Unlicensed Medicines >

      • Policy Development
      • Asset Strategy
      • Early Access
      • Real World Evidence
      • Post-Trial Access
      • Phased Launch and Non-Launch Markets
      • Medicine Shortages
      • Market Withdrawal/ Discontinuations
      • Consulting Services
    • Clinical Trial Services >
      Clinical Trial Services >

      Clinical Trial Services >

      • Comparator Sourcing and Ancillary Supply
      • Direct-to-site
      • Demand Driven Labelling & Distribution
      • Investigator Initiated Trials
      • Technical Consultancy
  • Global offices
    Global offices
    • Australia & New Zealand
    • Japan
    • Singapore
    • South Africa
    • United Kingdom
    • United States
  • Investors
    Investors
    • At a Glance
    • Financial Highlights
    • Investment Case
      Investment Case

      Investment Case

      • Business Model
      • Our Track Record
      • Market Overview
      • Strategy
      • Our Businesses
    • Share Tools
    • Results, Reports and Presentations
    • Quantum Archive
    • Financial Calendar
    • Press Releases
      Press Releases
      • Press Releases
      • Regulatory News
      • Email Alerts
    • Shareholder Services
      Shareholder Services
      • AGM
      • Registrar Services
      • Major Shareholders
      • Advisor Contacts
      • Analyst Coverage
    • AIM Rule 26
    • Corporate Governance
      Corporate Governance
      • Corporate Governance Statement
      • Board of Directors
      • Tax Strategy
  • Company
    Company
    • About Clinigen >
      About Clinigen >

      About Clinigen >

      • History
      • Responsible business
      • Operational excellence
      • Our brands
    • Careers
      Careers

      Careers

      • Frequently Asked Questions
      • Apply Online
      • Privacy Notice - Applicants
    • Newsroom
      Newsroom
      • Video Library
      • Press Releases
Global sites
  • About Cliniport
  • Login
Global sites
  • Clinigen France
  • Clinigen Germany

Press Releases

  • At a Glance
  • Financial Highlights
  • Investment Case
    • Business Model
    • Our Track Record
    • Market Overview
    • Strategy
    • Our Businesses
  • Share Tools
  • Results, Reports and Presentations
  • Quantum Archive
  • Financial Calendar
  • Press Releases
    • Press Releases
    • Regulatory News
    • Email Alerts
  • Shareholder Services
    • AGM
    • Registrar Services
    • Major Shareholders
    • Advisor Contacts
    • Analyst Coverage
  • AIM Rule 26
  • Corporate Governance
    • Corporate Governance Statement
    • Board of Directors
    • Tax Strategy
  • 2018
  • 2017
  • 2016
  • Archive
More
Filter by
  • 15 Nov 2018

    Board Appointment
    Related materials
    PDF (125.16KB)
  • 09 Oct 2018

    Clinigen Group Completes Acquisition of iQone Healthcare
    Related materials
    PDF (412.18KB)
  • 09 Oct 2018

    ANNUAL REPORT AND ACCOUNTS 2018
    Related materials
    PDF (3.46MB)
  • 09 Oct 2018

    Notice of AGM
    Related materials
    PDF (122.68KB)
  • 09 Oct 2018

    Proxy Form
    Related materials
    PDF (74.73KB)
  • 09 Oct 2018

    Annual Report and Accounts, and notice of AGM
    Related materials
    PDF (266.96KB)
  • 02 Oct 2018

    Clinigen Group Completes Acquisition of CSM
  • 27 Sep 2018

    Result of Placing
  • 27 Sep 2018

    Clinigen acquires Swiss based iQone Healthcare Holding
    Related materials
    PDF (105.80KB)
  • 27 Sep 2018

    Acquisition of CSM for initial consideration of $150 million
Our global offices
  • Australia & New Zealand
  • Japan
  • Singapore
  • South Africa
  • United Kingdom
  • United States
Site
tools
  • AE Reporting
  • Medical enquiries
  • Terms of use
  • Cookies
  • Privacy policy
  • UK Gender Pay Gap Report
  • Modern Slavery Statement
  • Access Online
  • Sitemap
  • Consumer Information Obligations
Access cliniport

Cliniport medicine finder provides Healthcare Professionals with safe and secure access to 10,000 licensed and unlicensed products.

Log In About Cliniport
Subscribe to our email alerts
  • Twitter
  • Vimeo
  • Linkedin
© Copyright 2018 Clinigen Group plc. By Emperor